Opinion|Videos|January 7, 2025
Empowering Patients: Strategies for Emotional Resilience and Support in Lymphoma Care
Panelists discuss the key challenges faced by patients with diffuse large B-cell lymphoma and follicular lymphoma at diagnosis, how these challenges evolve during treatment, and the emotional and psychological support strategies employed to help patients navigate their lymphoma journey.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are the key challenges that patients with diffuse large B-cell lymphoma (DLBCL) face at the time of diagnosis, and how do these challenges evolve throughout treatment?
- Can you discuss the same for patients with follicular lymphoma (FL)?
- How do you approach addressing the emotional and psychological challenges that patients with DLBCL and FL face, particularly when they first receive their diagnosis?
- What are the most important factors in helping patients navigate their journey with DLBCL or FL?
Advertisement
Related to this article
Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.
AI quantitative CT (UCLA QILD, Brainomix e-Lung) predicts FVC decline and drug response in PPF, strengthening biomarkers beyond spirometry in INBUILD.
Delphi consensus guides dermatology on spotting CTCL vs atopic dermatitis before/after dupilumab, using biopsy plus T-cell clonality testing and safer treatment switches.
Rosacea is likely missed, not rare, in skin of color, as low suspicion and hard-to-see redness delay diagnosis, said Hilary Baldwin, MD.
Hidradenitis suppurativa diagnosis often takes 7 to 10 years, and patients with skin of color often present with tunnels and scarring already in place.
In HIV, lymphoma survival tracks tumor stage and CD4 count, not viral suppression, a Spanish cohort shows.
Polyphenols show lab promise for endometriosis, but human evidence is thin, and the best resveratrol pain trial was negative.
Those using e-cigarettes were more likely to develop cataracts, and those receiving cataract surgery less likely to develop depression and anxiety.
Advertisement
Advertisement
Trending on AJMC
1
Using Complement Inhibitors in GA Comes With Pros and Cons
2
A New Mechanism for DME in the BRUNELLO Trial: Donald J. D’Amico, MD
3
Medicare Drug Price Negotiations Yield Uneven Out-of-Pocket Savings
4
New Mechanism of DME Treatment Highlights Clinical Trial Updates
5